GenePOC obtains CE marking for its GenePOC™ Carba test
GenePOC Inc., member of the Debiopharm Group, announces its third…
GenePOC to attend 29th ECCMID in Amsterdam, Netherlands, from April 13th to 16th
GenePOC will participate in the 29th ECCMID (European Congress…
GenePOC obtains FDA clearance for its GenePOC™ Strep A test
GenePOC Inc., member of the Debiopharm Group™, is proud to…
GenePOC to attend MEDLAB in Dubai from February 4-7 2019
Come visit our booth # Z3 C33 - Discover the power of the PIE…
GenePOC's Investment in SMRT Panels Validated by Medicare Decision
Read the entire Genomeweb interview to learn more on GenePOC's…
GENEPOC ANNOUNCES HEALTH CANADA APPROVAL OF ITS CDIFF TEST
Read the Press Release here.
GenePOC to attend AMP in San Antonio, USA from 31 of October to 3 of November 2018
Come visit our booth #1629 - Discover the power of the PIE and…
GenePOC to attend ID Week in San Francisco, USA from 3 to 7 of October 2018
Come visit our booth #1204 - Discover the power of the PIE and…
GenePOC to attend ASM in Atlanta, USA from 7 to 11 June 2018
GenePOC will participate in the ASM (American Society for Microbiology)…
Practical Patient Care Interview – Infection test for expectant mother
Practical Patient Care talks to Dr Mayra Bermudez Martinez, an…
GenePOC to attend 28th ECCMID in Madrid, Spain from 21 to 24 April
GenePOC will participate in the 28th ECCMID (European Congress…
GenePOC Signs Assay Development Contract for Diagnosis of Respiratory Infections with Novacyt !
Under the terms of the services agreement, Primerdesign will…